Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12253-015-0024-7.

Title:
Prognostic Factors for Breast Cancer: an Immunomorphological Update | Pathology & Oncology Research
Description:
The prognostic variability recorded within homogeneous groups of patients for anatomo-clinical disease stages has led to a more detailed biological characterization of breast cancer. Recently, the attention of the scientific community has focused on the role of tumor-infiltrating lymphocytes (TILs). Therefore, the need of an in-depth immunomorphological characterization of TILs has been emerged. The presence of TILs has been retrospectively investigated in 113 female cases of ductal carcinoma. An immunohistochemical investigation with CD3, CD4, CD8, CD20, CD56, granulysin, perforin-1, granzyme-B and TIA-1 was performed according to the standard procedures on all 17 cases with TILs evidence. TILs consisted of T and B lymphocytes: the prevalent population showed a T immunoprofile with a CD8-immunopositive killer subpopulation (Tk), close-linked to carcinomatous cells, and a CD4-immunopositive helper subpopulation (Th), inside the tumor. A time sequence (firstly T, then B) has been disclosed. Granulysin, perforin, granzyme-B and TIA-1 were expressed by Tk cells. The activated Tk cells secrete these mediators as a result of the binding to the tumor target cell, causing its lytic planned death. The cytotoxicity supported by Tk cells appears an important favorable prognostic factor. Therefore, a graduation system for TILs in breast cancer has been here proposed (absent, non-brisk, brisk).
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {๐Ÿ“š}

  • Health & Fitness
  • Science
  • Education

Content Management System {๐Ÿ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of link.springer.com audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,734,772 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {๐Ÿ’ธ}

We can't see how the site brings in money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {๐Ÿ”}

cancer, article, breast, pubmed, google, scholar, lymphocytes, prognostic, cas, tumorinfiltrating, tumor, roncati, tils, cells, central, research, privacy, cookies, content, barbolini, access, infiltrating, health, publish, search, pathology, luca, primary, predictive, modena, data, information, log, journal, oncology, factors, immunomorphological, november, piacentini, disease, ductal, carcinoma, granulysin, tia, cell, factor, response, chapter, discover, cytotoxic,

Topics {โœ’๏ธ}

fas-activated serine/threonine kinase tumour-infiltrating cd8+ lymphocytes month download article/chapter triple-negative breast cancer francesco piscioliย &ย teresa pusiol small-cell lung cancer node-negative breast cancer cd8-immunopositive killer subpopulation cd4-immunopositive helper subpopulation tumor-infiltrating immune cells anatomo-clinical disease stages jak2/stat4/perforin pathway breast tumor growth full article pdf tumor-infiltrating lymphocytes tumor infiltrating lymphocytes tumor target cell prognostic factors independent predictive factor privacy choices/manage cookies early breast cancer breast cancer treated breast cancer subtypes human breast cancer favorable prognostic marker primary systemic therapy prognostic variability recorded fas-mediated apoptosis invasive tumor front infiltrating ductal carcinoma article roncati depth immunomorphological characterization european economic area detailed biological characterization prevalent population showed lytic planned death related subjects evaluating jak2 inhibitors cryptotanshinone induces inhibition ethics declarations funding conditions privacy policy cytotoxic cd4+ article log tk cells appears neoadjuvant systemic therapy breast cancer accepting optional cookies pathological complete response federico piacentini article cite

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:Prognostic Factors for Breast Cancer: an Immunomorphological Update
         description:The prognostic variability recorded within homogeneous groups of patients for anatomo-clinical disease stages has led to a more detailed biological characterization of breast cancer. Recently, the attention of the scientific community has focused on the role of tumor-infiltrating lymphocytes (TILs). Therefore, the need of an in-depth immunomorphological characterization of TILs has been emerged. The presence of TILs has been retrospectively investigated in 113 female cases of ductal carcinoma. An immunohistochemical investigation with CD3, CD4, CD8, CD20, CD56, granulysin, perforin-1, granzyme-B and TIA-1 was performed according to the standard procedures on all 17 cases with TILs evidence. TILs consisted of T and B lymphocytes: the prevalent population showed a T immunoprofile with a CD8-immunopositive killer subpopulation (Tk), close-linked to carcinomatous cells, and a CD4-immunopositive helper subpopulation (Th), inside the tumor. A time sequence (firstly T, then B) has been disclosed. Granulysin, perforin, granzyme-B and TIA-1 were expressed by Tk cells. The activated Tk cells secrete these mediators as a result of the binding to the tumor target cell, causing its lytic planned death. The cytotoxicity supported by Tk cells appears an important favorable prognostic factor. Therefore, a graduation system for TILs in breast cancer has been here proposed (absent, non-brisk, brisk).
         datePublished:2015-11-20T00:00:00Z
         dateModified:2015-11-20T00:00:00Z
         pageStart:449
         pageEnd:452
         sameAs:https://doi.org/10.1007/s12253-015-0024-7
         keywords:
            Breast cancer
            Prognostic factors
            Histology
            Immunohistochemistry
            Tumor-infiltrating lymphocytes (TILs)
            Granulysin
            Cancer Research
            Oncology
            Pathology
            Immunology
            Biomedicine
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12253-015-0024-7/MediaObjects/12253_2015_24_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12253-015-0024-7/MediaObjects/12253_2015_24_Fig2_HTML.gif
         isPartOf:
            name:Pathology & Oncology Research
            issn:
               1532-2807
               1219-4956
            volumeNumber:22
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Luca Roncati
               affiliation:
                     name:University of Modena and Reggio Emilia, Policlinico Hospital
                     address:
                        name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
                        type:PostalAddress
                     type:Organization
                     name:Institute of Pathology
                     address:
                        name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Giuseppe Barbolini
               affiliation:
                     name:University of Modena and Reggio Emilia, Policlinico Hospital
                     address:
                        name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Federico Piacentini
               affiliation:
                     name:University of Modena and Reggio Emilia
                     address:
                        name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Francesco Piscioli
               affiliation:
                     name:Institute of Pathology
                     address:
                        name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Teresa Pusiol
               affiliation:
                     name:Institute of Pathology
                     address:
                        name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Antonio Maiorana
               affiliation:
                     name:University of Modena and Reggio Emilia, Policlinico Hospital
                     address:
                        name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Prognostic Factors for Breast Cancer: an Immunomorphological Update
      description:The prognostic variability recorded within homogeneous groups of patients for anatomo-clinical disease stages has led to a more detailed biological characterization of breast cancer. Recently, the attention of the scientific community has focused on the role of tumor-infiltrating lymphocytes (TILs). Therefore, the need of an in-depth immunomorphological characterization of TILs has been emerged. The presence of TILs has been retrospectively investigated in 113 female cases of ductal carcinoma. An immunohistochemical investigation with CD3, CD4, CD8, CD20, CD56, granulysin, perforin-1, granzyme-B and TIA-1 was performed according to the standard procedures on all 17 cases with TILs evidence. TILs consisted of T and B lymphocytes: the prevalent population showed a T immunoprofile with a CD8-immunopositive killer subpopulation (Tk), close-linked to carcinomatous cells, and a CD4-immunopositive helper subpopulation (Th), inside the tumor. A time sequence (firstly T, then B) has been disclosed. Granulysin, perforin, granzyme-B and TIA-1 were expressed by Tk cells. The activated Tk cells secrete these mediators as a result of the binding to the tumor target cell, causing its lytic planned death. The cytotoxicity supported by Tk cells appears an important favorable prognostic factor. Therefore, a graduation system for TILs in breast cancer has been here proposed (absent, non-brisk, brisk).
      datePublished:2015-11-20T00:00:00Z
      dateModified:2015-11-20T00:00:00Z
      pageStart:449
      pageEnd:452
      sameAs:https://doi.org/10.1007/s12253-015-0024-7
      keywords:
         Breast cancer
         Prognostic factors
         Histology
         Immunohistochemistry
         Tumor-infiltrating lymphocytes (TILs)
         Granulysin
         Cancer Research
         Oncology
         Pathology
         Immunology
         Biomedicine
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12253-015-0024-7/MediaObjects/12253_2015_24_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12253-015-0024-7/MediaObjects/12253_2015_24_Fig2_HTML.gif
      isPartOf:
         name:Pathology & Oncology Research
         issn:
            1532-2807
            1219-4956
         volumeNumber:22
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Luca Roncati
            affiliation:
                  name:University of Modena and Reggio Emilia, Policlinico Hospital
                  address:
                     name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
                     type:PostalAddress
                  type:Organization
                  name:Institute of Pathology
                  address:
                     name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Giuseppe Barbolini
            affiliation:
                  name:University of Modena and Reggio Emilia, Policlinico Hospital
                  address:
                     name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Federico Piacentini
            affiliation:
                  name:University of Modena and Reggio Emilia
                  address:
                     name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Francesco Piscioli
            affiliation:
                  name:Institute of Pathology
                  address:
                     name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Teresa Pusiol
            affiliation:
                  name:Institute of Pathology
                  address:
                     name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Antonio Maiorana
            affiliation:
                  name:University of Modena and Reggio Emilia, Policlinico Hospital
                  address:
                     name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Pathology & Oncology Research
      issn:
         1532-2807
         1219-4956
      volumeNumber:22
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Modena and Reggio Emilia, Policlinico Hospital
      address:
         name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
         type:PostalAddress
      name:Institute of Pathology
      address:
         name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
         type:PostalAddress
      name:University of Modena and Reggio Emilia, Policlinico Hospital
      address:
         name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
         type:PostalAddress
      name:University of Modena and Reggio Emilia
      address:
         name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
         type:PostalAddress
      name:Institute of Pathology
      address:
         name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
         type:PostalAddress
      name:Institute of Pathology
      address:
         name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
         type:PostalAddress
      name:University of Modena and Reggio Emilia, Policlinico Hospital
      address:
         name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Luca Roncati
      affiliation:
            name:University of Modena and Reggio Emilia, Policlinico Hospital
            address:
               name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
               type:PostalAddress
            type:Organization
            name:Institute of Pathology
            address:
               name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Giuseppe Barbolini
      affiliation:
            name:University of Modena and Reggio Emilia, Policlinico Hospital
            address:
               name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
               type:PostalAddress
            type:Organization
      name:Federico Piacentini
      affiliation:
            name:University of Modena and Reggio Emilia
            address:
               name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
               type:PostalAddress
            type:Organization
      name:Francesco Piscioli
      affiliation:
            name:Institute of Pathology
            address:
               name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
               type:PostalAddress
            type:Organization
      name:Teresa Pusiol
      affiliation:
            name:Institute of Pathology
            address:
               name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
               type:PostalAddress
            type:Organization
      name:Antonio Maiorana
      affiliation:
            name:University of Modena and Reggio Emilia, Policlinico Hospital
            address:
               name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
      name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
      name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
      name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Oncology, University of Modena and Reggio Emilia, Modena, Italy
      name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
      name:Provincial Health Care Services, Santa Maria del Carmine Hospital, Institute of Pathology, Rovereto, Italy
      name:Department of Diagnostic and Clinical Medicine and of Public Health, Section of Pathology, University of Modena and Reggio Emilia, Policlinico Hospital, Modena, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {๐Ÿ”—}(87)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Clipboard.js
  • Prism.js

CDN Services {๐Ÿ“ฆ}

  • Crossref

4.79s.